Complete remission after rituximab therapy of pemphigus: Real-world evidence on dosing regimens and retreatment strategies. (PubMed, JID Innov) - Oct 11, 2026 - "For subsequent treatment, maintenance rituximab infusions every 6 months were associated with a shorter time to initial achievement of CR off therapy and a longer time to relapse than an on-demand approach; however, both achieved similar overall rates of CR off therapy. These findings support the benefit of weight-adjusted dosing for the first rituximab cycle and provide real-world data on outcomes of maintenance versus on-demand rituximab infusions for pemphigus therapy."
HEOR • Journal • Real-world evidence
|
|
Aimee S Payne; Chuda Rujitharanawong; Sasima Tongsai
|